Dr. Berland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3305 Taubman Center
SPC 5352
Ann Arbor, MI 48109Phone+1 734-615-6379Fax+1 734-647-9443
Summary
- Dr. Daniel Berland, located in Ann Arbor, MI, is an Internal Medicine specialist with a subspecialty in Addiction Medicine. He completed his residency in Internal Medicine at Henry Ford Hospital and graduated from Ohio State University College of Medicine in 1980. He currently serves as an Emeritus Clinical Associate Professor at the University of Michigan Medical Center and has been at Michigan Medicine since 2006. His expertise includes acute and chronic pain management, opioid management and opioid deprescribing. He has several publications on pain management, with his work cited multiple times.
Education & Training
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1980 - 1983
- Ohio State University College of MedicineClass of 1980
Certifications & Licensure
- MI State Medical License 2006 - 2025
- IL State Medical License 1983 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Addiction MedicineAddiction Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsEfficacy and Safety of Low Dose Naltrexone for Chronic Pain.Madison N Irwin, David A Cooke, Daniel Berland, Vincent D Marshall, Michael A Smith
Journal of Pain & Palliative Care Pharmacotherapy. 2024-03-01 - 19 citationsDexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphineChad M. Brummett, DO Kavita A. Trivedi, Anna Dubovoy, Daniel W. Berland
Journal of Opioid Management. 2018-01-29 - 3 citationsPressure sensitivity and phenotypic changes in patients with suspected opioid-induced hyperalgesia being withdrawn from full mu agonists.Ronald A. Wasserman, Afton L. Hassett, Steven E. Harte, Jenna Goesling, Herbert L. Malinoff
Journal of Nature and Science. 2017-02-15
Press Mentions
- Non-Pharmacological Approaches to Musculoskeletal PainAugust 27th, 2017
- ACP: What to Do About the High Price of Drugs?April 3rd, 2017
- Medications, Mindfulness and More Alternatives to Opioids for Treating PainFebruary 5th, 2017
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: